Montaudié Henri

25PUBLICATIONS
64CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersElectrometallurgyNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 26, 2026
Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study.

|Nov 24, 2025
Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomas.

Damien Sanogo, Romain Levard, Julie Cassecuel

|Sep 26, 2025
CD206+CD14- Skin-Resident Macrophages and DC-T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma.

Roxane Elaldi, Aïda Meghraoui, Axel Elaldi

|Sep 13, 2025
Reconstruction After Wide Excision of the Nail Apparatus in the Treatment of Melanoma: A Systematic Literature Review.

Luc Chouquet, Feriel Boukari, Thierry Balaguer

|Jun 27, 2025
BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203.

Iván Márquez-Rodas, Caroline Dutriaux, Philippe Saiag

|Jun 28, 2023
Comparative Performance of Four Staging Classifications to Select «High-Risk» Head and Neck Cutaneous Squamous Cell Carcinomas.

Roxane Elaldi, Emmanuel Chamorey, Renaud Schiappa

Pageof 5

Frequent Collaborators

16 joint publications

Thierry Passeron

2 joint publications

Fabienne Anjuère

2 joint publications

J-P Lacour

2 joint publications

Alain Dupuy